Express Scripts Holding (ESRX) Stock Analysis
NASDAQHealthcareMedical - Pharmaceuticals
What Express Scripts Holding does
Express Scripts, established in 1986, functions as a pharmacy benefit management (PBM) enterprise. It offers a comprehensive array of integrated services, including the processing of prescription claims, home delivery of medications, strategic management of drug formularies, specialized pharmaceutical support via its Accredo division, and insightful analytics derived from drug usage data. The company became a subsidiary of Cigna in December 2018, following its acquisition for $54 billion.
Key metrics
ETFs linked to ESRX
Broad-market and Healthcare sector ETFs an investor holding Express Scripts Holding is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how ESRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze ESRX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Express Scripts Holding?
- Express Scripts Holding trades under the ticker ESRX on NASDAQ.
- Which exchange is ESRX listed on?
- ESRX is listed on NASDAQ.
- What sector does Express Scripts Holding operate in?
- Express Scripts Holding is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
- How can PortView help analyze ESRX in a portfolio?
- PortView shows ESRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.